1.	Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery Phase: Phase IV Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 03/2007, NCT00719017
2.	Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CDR0000521447; P06.031, CKTO-2006-04, ISRCTN14387080, P06.031-PORTEC-3, 2007-004917-33, CKTO-PORTEC-3, EU-20664, NCT00411138
3.	Prospective Randomized Open Label Study of the Treatment of Therapy-Associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium - Phase: Phase III Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2006-002948-28, KKS-73-05, NCT00444093
4.	The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: SARC-GYN1, NCT00162721
5.	Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VRAM M-20070240, NCT00647569
6.	Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: GOG-0249, GOG-0249, NCT00807768
7.	Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TOTEM, NCT00916708
8.	Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and older Sponsor: NCI Protocol IDs: GOG-0258, GOG-0258, NCT00942357
9.	Study Comparing Isolated Pelvic Perfusion With TNF-a 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 to 76 Sponsor: Other Protocol IDs: PIP2, CSET 1443, NCT00949039
10.	Letrozole as a Treatment of Endometrial Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: 200917341, CFEM 345AUS63, NCT00997373
11.	Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: ENGOT-EN2-DGCG/EORTC55102, 2010-023081-52, NCT01244789
12.	A Trial Comparing Morcellation With Electrical Resection for Removal of Uterine Polyps Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 16 and over Sponsor: Other Protocol IDs: PPS-MERT-01, NCT01509313
13.	Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: 70 and over Sponsor: Other Protocol IDs: TOMOGYN - 1105, NCT01641497
14.	Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000738944, RTOG-1203, NCT01672892
15.	A Clinical Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BBI608-201, NCT01325441
16.	Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 05-20025/20288, NCT01580696
17.	Aerosol IL-2 for Pulmonary Metastases Phase: Phase II, Phase I Type: Treatment Status: Active Age: 12 and over Sponsor: Other Protocol IDs: 2010-0700, NCT01590069
18.	Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ISS22810034, NCT01650376
19.	Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UTHSC-MS-96205, NCI-V97-1356, NCT00003135
20.	A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients Phase: Phase II Type: Treatment Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: KGOG2001, NCT00373620
21.	Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: NCI Protocol IDs: GOG-0238, GOG-0238, NCT00492778
22.	External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: IOSI-RO0402, RO0402, NCT00637637
23.	A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EndoRT, WIRB PRO NUM: 20050247, NCT00285415
24.	Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: GRID, NCT00765570
25.	Treatment of Patients With RAD001 Who Have Progressive Sarcoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CRAD001C24114, EUDRACT- Nr. 2007-005294-60, NCT00767819